81 related articles for article (PubMed ID: 18510939)
41. p53 mutant human glioma cells are sensitive to UV-C-induced apoptosis due to impaired cyclobutane pyrimidine dimer removal.
Batista LF; Roos WP; Kaina B; Menck CF
Mol Cancer Res; 2009 Feb; 7(2):237-46. PubMed ID: 19208740
[TBL] [Abstract][Full Text] [Related]
42. Induction of apoptosis and inhibition of telomerase activity in human lung carcinoma cells by the water extract of Cordyceps militaris.
Park SE; Yoo HS; Jin CY; Hong SH; Lee YW; Kim BW; Lee SH; Kim WJ; Cho CK; Choi YH
Food Chem Toxicol; 2009 Jul; 47(7):1667-75. PubMed ID: 19393284
[TBL] [Abstract][Full Text] [Related]
43. Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.
Konstantakou EG; Voutsinas GE; Karkoulis PK; Aravantinos G; Margaritis LH; Stravopodis DJ
Int J Oncol; 2009 Aug; 35(2):401-16. PubMed ID: 19578756
[TBL] [Abstract][Full Text] [Related]
44. Propofol protects hepatic L02 cells from hydrogen peroxide-induced apoptosis via activation of extracellular signal-regulated kinases pathway.
Wang H; Xue Z; Wang Q; Feng X; Shen Z
Anesth Analg; 2008 Aug; 107(2):534-40. PubMed ID: 18633031
[TBL] [Abstract][Full Text] [Related]
45. Expression of E1AF, an ets-family transcription factor, is correlated with the invasive phenotype of oral squamous cell carcinoma.
Hida K; Shindoh M; Yoshida K; Kudoh A; Furaoka K; Kohgo T; Fujinaga K; Totsuka Y
Oral Oncol; 1997 Nov; 33(6):426-30. PubMed ID: 9509127
[TBL] [Abstract][Full Text] [Related]
46. Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy.
Albertini V; Jain A; Vignati S; Napoli S; Rinaldi A; Kwee I; Nur-e-Alam M; Bergant J; Bertoni F; Carbone GM; Rohr J; Catapano CV
Nucleic Acids Res; 2006; 34(6):1721-34. PubMed ID: 16571899
[TBL] [Abstract][Full Text] [Related]
47. Novel mithramycins abrogate the involvement of protein factors in the transcription of cell cycle control genes.
Vizcaíno C; Mansilla S; Núñez LE; Méndez C; Salas JA; Morís F; Portugal J
Biochem Pharmacol; 2012 Nov; 84(9):1133-42. PubMed ID: 22981341
[TBL] [Abstract][Full Text] [Related]
48. Mithramycin inhibits etoposide resistance in glucose-deprived HT-29 human colon carcinoma cells.
Lee EM; Park HR; Hwang JH; Park DJ; Chang KS; Kim CJ
J Microbiol Biotechnol; 2007 Nov; 17(11):1856-61. PubMed ID: 18092471
[TBL] [Abstract][Full Text] [Related]
49. Differential inhibition of restriction enzyme cleavage by chromophore-modified analogues of the antitumour antibiotics mithramycin and chromomycin reveals structure-activity relationships.
Mansilla S; Garcia-Ferrer I; Méndez C; Salas JA; Portugal J
Biochem Pharmacol; 2010 May; 79(10):1418-27. PubMed ID: 20093108
[TBL] [Abstract][Full Text] [Related]
50. Mithramycin inhibits human epithelial carcinoma cell proliferation and migration involving downregulation of Eps8 expression.
Yang TP; Chiou HL; Maa MC; Wang CJ
Chem Biol Interact; 2010 Jan; 183(1):181-6. PubMed ID: 19799886
[TBL] [Abstract][Full Text] [Related]
51. Elevated beta1,4-galactosyltransferase I in highly metastatic human lung cancer cells. Identification of E1AF as important transcription activator.
Zhu X; Jiang J; Shen H; Wang H; Zong H; Li Z; Yang Y; Niu Z; Liu W; Chen X; Hu Y; Gu J
J Biol Chem; 2005 Apr; 280(13):12503-16. PubMed ID: 15611127
[TBL] [Abstract][Full Text] [Related]
52. EPS8 inhibition increases cisplatin sensitivity in lung cancer cells.
Gorsic LK; Stark AL; Wheeler HE; Wong SS; Im HK; Dolan ME
PLoS One; 2013; 8(12):e82220. PubMed ID: 24367505
[TBL] [Abstract][Full Text] [Related]
53. In vitro inhibition of c-myc transcription by mithramycin.
Hardenbol P; Van Dyke MW
Biochem Biophys Res Commun; 1992 Jun; 185(2):553-8. PubMed ID: 1535193
[TBL] [Abstract][Full Text] [Related]
54. The aureolic acid family of antitumor compounds: structure, mode of action, biosynthesis, and novel derivatives.
Lombó F; Menéndez N; Salas JA; Méndez C
Appl Microbiol Biotechnol; 2006 Nov; 73(1):1-14. PubMed ID: 17013601
[TBL] [Abstract][Full Text] [Related]
55. Semi-synthetic mithramycin SA derivatives with improved anticancer activity.
Scott D; Chen JM; Bae Y; Rohr J
Chem Biol Drug Des; 2013 May; 81(5):615-24. PubMed ID: 23331575
[TBL] [Abstract][Full Text] [Related]
56. Insight into mithramycin disruption of ETS transcription leads to improved understanding of more selective analogs.
Woldemichael GM; O'Keefe BR
Structure; 2021 May; 29(5):401-403. PubMed ID: 33961789
[TBL] [Abstract][Full Text] [Related]
57. Role of Mg++ in the mithramycin-DNA interaction: evidence for two types of mithramycin-Mg++ complex.
Aich P; Dasgupta D
Biochem Biophys Res Commun; 1990 Dec; 173(2):689-96. PubMed ID: 2148084
[TBL] [Abstract][Full Text] [Related]
58. Enhanced Glucose Requirement in Human Hepatoma-derived HuH-7 Cells by Forced Expression of the bcl-2 Gene.
Okamoto K; Muraguchi T; Shidoji Y
J Clin Biochem Nutr; 2008 Sep; 43(2):101-8. PubMed ID: 18818743
[TBL] [Abstract][Full Text] [Related]
59. Global gene expression profiling data analysis reveals key gene families and biological processes inhibited by Mithramycin in sarcoma cell lines.
Kulkarni KK; Bankar KG; Shukla RN; Das C; Banerjee A; Dasgupta D; Vasudevan M
Genom Data; 2015 Mar; 3():8-14. PubMed ID: 26484141
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
